About physIQ
physIQ’s accelerateIQ is a medical-grade end-to-end solution used to collect and analyze real-world physiological data in near-real-time. The solution streams continuous wearable biosensor data in near-real-time to the cloud where it is processed by FDA-cleared machine-learning digital biomarkers to support both clinical safety monitoring and/ or appropriate endpoints. Configurable clinical events indicate to clinician/investigator when there are potential safety issues with an enrolled patient, enabling AE mitigation strategies and novel pharmacovigilance workflows. With this, it is ideal for clinical studies that can benefit from powerful, continuous safety monitoring. Beyond this, physIQ’s portfolio of digital biomarkers can also support both safety and efficacy endpoints.
Images
![](https://www.rarediseaseday.org/wp-content/uploads/physIQ-Home-Page.jpg)
![](https://www.rarediseaseday.org/wp-content/uploads/End-to-End-for-Scale-10-25-2021.jpg)
![](https://www.rarediseaseday.org/wp-content/uploads/datahub.jpg)
![](https://www.rarediseaseday.org/wp-content/uploads/The-team-2022.jpg)
![](https://www.rarediseaseday.org/wp-content/uploads/physIQ-Home-Page.jpg)
![](https://www.rarediseaseday.org/wp-content/uploads/End-to-End-for-Scale-10-25-2021.jpg)
![](https://www.rarediseaseday.org/wp-content/uploads/datahub.jpg)
![](https://www.rarediseaseday.org/wp-content/uploads/The-team-2022.jpg)